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Abstract
Current biomedical research methods to evaluate the efficacy of Chinese medicine interventions
are often conceptually incompatible with the theory and clinical practice of Chinese medicine. In
this commentary, we (1) highlight the theory and principles underlying Chinese medicine clinical
practice; (2) use ginseng as an example to describe clinical indications in Chinese medicine; (3)
propose a framework guided by Chinese medicine theory for the evaluation of study designs in
Chinese medicine research; and (4) evaluate 19 randomized, double-blind, placebo-controlled trials
of ginseng. Our analysis indicates that all 19 trials with both positive and negative results confirm
the specific effects of ginseng indicated by Chinese medicine theory. Study designs guided by
Chinese medicine theory are necessary to validate and improve future randomized controlled
clinical trials in Chinese medicine.
Background
Chinese medicine remains popular in China where tradi-
tional herbal preparations are estimated to account for
30–50% of the total medicinal consumption [1]. Chinese
medicine has also been gaining popularity in the West [1-
3]. However, Chinese medicine lacks funding and leading
scientists to conduct scientific research (e.g. randomized
controlled trials) [4].
The study of ginseng provides an example of the research
challenges in Chinese medicine. Highly valued in the Chi-
nese medicine classics and widely used in China for more
than two thousand years, ginseng has yet to prove its
safety and efficacy through clinical trials [5,6], which,
many investigators believe, may be attributed to a para-
digm conflict and the poor quality of some clinical trials
[7,8].
We found that this paradigm conflict may be resolved by
using study designs guided by Chinese medicine theory.
Chinese medicine theory
Chinese medicine is a syndrome-oriented holistic medical
system that is conceptually distinct from its Western coun-
terpart. According to Chinese medicine theory, a syn-
drome is a group of associated signs and symptoms
described in terms of Yin and Yang, Qi, and Xue (blood)
[9]. All illnesses fall into eight principal categories used to
guide the prevention and treatment of illnesses [10].
These categories are Yin and Yang, Biao (exterior) and Li
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(interior), Han (coldness) and Re (heat), and Xu (defi-
ciency) and Shi  (excess). Western medicine, however,
views a disease or syndrome as pathological changes of
specific biological processes [1]. As a result, the syn-
dromes in Chinese medicine do not always correspond
with Western classifications of diseases and syndromes.
For instance, hypertension may be related to syndromes
of Gan (liver) Yang ascending, Yin deficiency of liver and
kidney, flaming liver fire, stagnation of phlegm, Xue stasis
and/or dual Yin/Yang deficiency [11]. Conversely, Qi-
deficiency syndrome is related to chronic obstructive pul-
monary disease [12], lung cancer [13], coronary heart dis-
ease [14] and persistent allergic rhinitis [15].
Herbal medications
In Chinese medicine, medicinal herbs are categorized
according to the concepts of Yin, Yang, Qi,  Xue,  Jing
(essence) and Jin (body fluid) [16]. In general, 'tonics' are
used to treat deficiency and 'clear-ups' are used to treat
excess [9].
Considered the premium Qi-tonifying herb to treat vari-
ous illnesses [16], ginseng is thought to have the major
indications as follows:
(1) Impalpable pulse caused by severe Qi-deficiency;
(2) Shortness of breath, feeble voice, spontaneous sweat-
ing and a weak pulse caused by Fei (lung) Qi-deficiency;
(3) Fatigue, anorexia and loose bowels caused by Pi
(spleen) Qi-deficiency;
(4) Fever and strong thirst caused by Qi-deficiency;
(5) Palpitation, insomnia and forgetfulness caused by
dual deficiency of Qi and Xue.
Study design compatible with Chinese medicine theory
Research topics
Instead of evaluating the efficacy of ginseng in all patients
suffering from a single disease, researchers should focus
on those patients with Qi-deficiency syndrome. Qi-defi-
ciency causes decreased visceral functions and lowered
immune resistance, leading to various diseases. The man-
ifestations of Qi-deficiency include lassitude, shortness of
breath, feeble voice, dizziness, spontaneous perspiration,
susceptibility to cold, pale tongue and weak pulse [10].
Participants
Chinese medicine practitioners prescribe herbal medica-
tions to rectify disharmony in a patient's system [16].
Healthy individuals should not participate in treatment
groups in Chinese medicine studies. This explains the neg-
ative results from the ginseng studies in which healthy
individuals participated [17-21].
Ginseng is a Qi-tonifying herb to treat five major syn-
dromes [16] caused by Qi-deficiency. Therefore, we argue
that only studies in which participants are diagnosed with
Qi-deficiency are valid to evaluate ginseng's efficacy [22-
25].
Herbal species
While at least eight species of ginseng are commercially
available [26], only two major species, namely Panax gin-
seng (Chinese or Korean ginseng) and Panax quinquefolius
(American ginseng), are used as medicinal herbs world-
wide. According to Chinese medicine theory, the proper-
ties and functions of these two species are quite different
[16]. While P. ginseng enhances Yang, P. quinquefolius
nourishes Yin. A search for randomized controlled trials
of ginseng in PubMed (7 September 2008) found that
about one-third of the studies did not mention the gin-
seng species used and that very few studies addressed the
species issue.
Herbal quality
Herbal quality may affect research results. Different
batches of P. ginseng [27,28] or P. quinquefolius [29] pro-
duced opposing study results respectively on acute post-
prandial glycemia. The primary active ingredients in
ginseng are ginsenosides. G115, a ginsenoside-based
standardized extract of P. ginseng, may help assess the effi-
cacy and safety of ginseng. In fact, G115 was used in most
P. ginseng (single herb) trials reviewed in this paper.
Herbal formulae
In Chinese medicine, herbs are often formulated to
achieve increased therapeutic effects and reduced toxicity
or side effects [16]. Results from clinical trials on herbal
formulae confirm this practice. A Japanese trial found that
a 7-herb formula was effective in preventing liver cancer in
cirrhosis patients [30]. Two British trials showed that a 10-
herb formula was effective in treating a severe atopic
eczema [31,32]. No single herbal ingredient explains the
efficacy in these studies [33]. Furthermore, ginseng herbal
formulae were shown to be effective in treating chronic
pulmonary disease [22,34], congenital heart disease
[35,36], mild cognitive impairment [37], coronary heart
disease [38] and nasopharyngeal carcinoma [39].
Herbal safety
Certain Chinese medicine herbs are toxic and others may
have adverse effects when used improperly [16]. A condi-
tion known as the ginseng abuse syndrome is character-
ized by heart palpitations, heaviness in the chest, high
blood pressure, dizziness, insomnia, agitation, restless-
ness, nausea, vomiting, abdominal pain and/or bloating,
diarrhea, possible upper digestive tract bleeding, edema,
and red skin rash [40]. Most of these reported adverse
effects are common manifestations of Qi-excess and Qi-Chinese Medicine 2009, 4:3 http://www.cmjournal.org/content/4/1/3
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stasis. While all clinical trials should document adverse
effects, only one trial did do so [41].
Re-examination of equivocal ginseng trial results
To exemplify our framework of experimental study
design, we searched and analyzed randomized controlled
trials of ginseng in PubMed. The inclusion criteria were
single herb ginseng trials with a sample size of ≥20. We
selected trials of single herb ginseng because the majority
of the trials belonged to this category. Nineteen clinical
trials were selected for analysis according to the inclusion
criteria (Table 1) [42-46]. Most of the trials were consid-
ered good based on a trial quality evaluation scale [47].
Research topic
Out of the 19 trials, nine had negative results, ten had pos-
itive results, and none targeted ginseng's efficacy on Qi-
deficiency syndromes.
Participants
Both healthy and unhealthy participants were evaluated
for the effects of ginseng. Seven out of the nine trials with
negative results involved healthy participants, whereas
eight out of the ten studies with positive results had par-
ticipants with Qi-deficiency manifested by cancer, impo-
tence and pulmonary disease. Ellis et al. [48] investigated
the time-dependent effects of P. ginseng on the quality of
Table 1: Summary of results from single herb ginseng clinical trials
Trial quality* Research topic Participants (n) Herb species Chinese medicine 
theory
Reference
Negative results
Allen JD et al. 
(1998)
4 Exercise performance Healthy young (28) P. ginseng No Qi-deficiency [17]
Cardinal BJ et al. 
(2001)
4 Psychological well-
being
Healthy young adults (83) P. ginseng No Qi-deficiency [18]
Caron MF et al. 
(2002)
3 Cardiovascular function Healthy adults (30) P. ginseng No Qi-deficiency [42]
Dowling EA et al. 
(1996)
3 Exercise performance Highly trained distance 
runners (20)
Acanthopanax 
senticosus
No Qi-deficiency [43]
Engels HJ et al. 
(1997)
3 Physiologic and 
psychological 
responses
Healthy adults (36) P. ginseng No Qi-deficiency [21]
Engels HJ et al. 
(2001)
3 Exercise & short-term 
recovery
Healthy active women (24) P. ginseng No Qi-deficiency [20]
Engels HJ et al. 
(2003)
3 Physical performance 
heart rate recovery
Active healthy adults (38) P. ginseng No Qi-deficiency [19]
Stavro PM et al. 
(2006)
3 Blood pressure and 
renal function
Hypertension (52) P. quinquefolius Inappropriate herb 
species
[49]
Wiklund IK et al. 
(1999)
N/A Quality of life & 
physiological 
parameters
Symptomatic 
postmenopausal women 
(384)
P. ginseng Inappropriate herb 
species
[51]
Positive results
Cicero AF et al. 
(2004)
2 Quality of life Elderly hypertensive and 
digitalized (20)
Acanthopanax 
senticosus
Appropriate herb 
species
[53]
de Andrade E et al. 
(2007)
2 Sexual function Erectile dysfunction (60) P. ginseng Qi-Deficiency [44]
Ellis JM et al. (2002) 5 Quality of life Healthy young (30) P. ginseng Marginal Qi-
deficiency
[48]
Gross D et al. 
(2002)
N/A Respiratory function Chronic Obstructive 
Pulmonary Disease 
(COPD) (92)
P. ginseng Qi-Deficiency [22]
Hong B et al. (2002) 3 Sexual function Erectile dysfunction (45) P. ginseng Qi-Deficiency [45]
Kim JH et al. (2006) 3 Quality of life Cancer (53) P. ginseng Qi-Deficiency [23]
Liang MT et al. 
(2005)
3 Endurance exercise Untrained adults (29) P. notoginseng Appropriate herb 
species
[54]
McElhaney JE et al. 
(2004)
3 Acute respiratory 
illness
Sub healthy seniors(198) P. quinquefolius Qi-Deficiency [24]
McElhaney JE et al. 
(2006)
5 Acute respiratory 
illness
Sub healthy adults and 
seniors (43)
P. quinquefolius Qi-Deficiency [46]
Predy GN et al. 
(2005)
5 Cold Sub healthy adults (323) P. quinquefolius Qi-Deficiency [25]
*Trial quality evaluation scale [47]
0–2: poor quality
3–5: high quality
N/A: full text unavailable for quality evaluationChinese Medicine 2009, 4:3 http://www.cmjournal.org/content/4/1/3
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life in a healthy young adult population. In this case, the
participants had marginal Qi-deficiency as young adults
are at the stage of 'gradual filling of Qi and Xue' [9] accord-
ing to Chinese medicine theory.
Herbal species/safety
The species of ginseng may be a confounding factor in the
interpretation of trial results, which is illustrated by four
trials as follows (Table 1).
Stavro et al. [40] enrolled 52 hypertensive participants to
evaluate the long-term effects of P. quinquefolius on blood
pressure [49]. Long-term use of ginseng was reported to be
associated with the development of hypertension, which
was refuted by Stavro et al. In Chinese medicine practice,
however, P. quinquefolius, unlike its cousin P. ginseng, is in
fact used to treat hypertension in some cases.
Wiklund et al. [50] reported a trial in which 384 sympto-
matic postmenopausal women were assessed for the
effects of P. ginseng on the quality of life and physiological
parameters. Postmenopausal symptoms such as hot
flashes are often regarded as Shen (kidney) Yin-deficiency
[51] and are treated with P. quinquefolius rather than P.
ginseng. Moreover, the use of P. ginseng in this study was
contraindicated and might have produced adverse effects.
Cicero et al. [52] studied 20 elderly hypertensive and digi-
talized patients treated with Acanthopanax senticosus (Sibe-
rian ginseng) which is a mild Qi-tonic for an unspecific
feeling of fatigue, a sign of Qi-deficiency [53]. Hyperten-
sion is manifested in five syndromes [11], of which Qi-
deficiency is only a minor one. The positive results from
this trial were due to the fact that A. senticosus, an alterna-
tive Qi-tonic, was used [16].
Liang et al. [54] found that P. notoginseng improved endur-
ance time to exhaustion and lowered mean blood pres-
sure in 29 untrained young adults during an endurance
exercise. P. notoginseng is another important ginseng spe-
cies classified as homeostatic medicine to arrest bleeding
and removes stagnant Xue.
Conclusion
Our analysis of 19 randomized controlled clinical trials of
single herb ginseng shows that all the trials with both neg-
ative and positive results confirm the specific effects of
ginseng indicated by Chinese medicine theory. Therefore,
study designs guided by Chinese medicine theory are nec-
essary to validate and improve future randomized con-
trolled clinical trials in Chinese medicine.
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